Physician profile
Ryan J Kehoe
NPI 1184675365
$3,474.77
in general payments reported to CMS, 2019-2025
16 companies · $185 in 2025
The $185 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $421 · 2020: $273 · 2021: $153 · 2022: $117 · 2023: $1,614 · 2024: $712 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,264 · Consulting Fee: $1,246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,264.11 |
| Consulting Fee | $1,246.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Catalyst Orthoscience | $1,246.17 | 2023 | Catalyst Total Csr |
| Ferring Pharmaceuticals INC. | $634.79 | 2019-2025 | Euflexxa |
| Conformis, INC. | $510.91 | 2019-2020 | |
| Smith+Nephew, INC. | $345.22 | 2021-2024 | Bone Anchors With Arthroscopic Delivery System, Q-Fix, Intellio Link Werewolf |
| Depuy Synthes Sales INC. | $227.32 | 2020-2025 | Monovisc, Orthovisc |
| Fidia Pharma USA INC. | $168.44 | 2023-2025 | Hymovis, Triluron, Hyalgan |
| Bioventus LLC | $120.88 | 2021-2024 | Gelsyn-3, Durolane |
| Sanofi-Aventis U.S. LLC | $73.93 | 2020-2024 | |
| Stryker Corporation | $31.75 | 2020 | |
| Heron Therapeutics, INC. | $27.16 | 2025 | Zynrelef |
| Convatec INC. | $20.81 | 2021 | |
| Electronic Waveform Lab, INC. | $19.34 | 2024 | |
| Avanos Medical | $19.01 | 2024 | Trivisc Sodium Hyaluronate |
| Aroa Biosurgery Incorporated | $16.36 | 2023 | |
| Wright Medical Technology, INC. | $12.68 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$45,259.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Kehoe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.